News

Pursuant to the terms of the agreement, Impulse Monitoring (IMI) will offer to all of Health Management Associates’s (HMA) 56 hospitals its comprehensive intraoperative neuromonitoring (IONM) services, including

In addition to the closing purchase price, Isis will receive earn out payments from Abbott tied to post-closing sales of Ibis systems, including instruments and assay kits. Previously,

Located in regions of the brain responsible for Parkinson’s disease, Omeros is the first to link its novel target to the treatment of any movement disorder, including Parkinson’s

Under the agreement, Keata will be the third party supplier to the multi-national consumer healthcare company for the products for an initial two-year term commencing from January 1,

Previously, Duramed, a subsidiary of Barr Pharmaceuticals, has announced that the FDA has accepted for review its biologics license application for the vaccines. The vaccines will be used

The license authorized making and selling cellular and animal models in a restricted field, for research uses only expressly excluding the use of such product for any commercial

The new prescription acne treatment received approval from the FDA in December, 2008 and will be on pharmacy shelves in the US in the first quarter of 2009.

Neosalus, formulated with Quinnova’s patented Proderm Technology, provides skin barrier repair, protection, and moisturization. Christopher Hensby, senior vice president of Quinnova, said: “To treat recalcitrant skin conditions such

Mr Vargas joined Depomed as vice president of business development in December 2002, while Ms Cameron joined Depomed as controller in July 2007 and was named interim principal